New Mexico
Cancer observational studies in New Mexico
12 cancer observational studies are recruiting participants at sites in 4 cities across New Mexico as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every New Mexico city with a recruiting study
By research area: Lung Cancer (5), Breast Cancer (4), Lymphoma (1), Melanoma (1), Pancreatic Cancer (1).
Albuquerque (10), Farmington (2), Las Cruces (2), Rio Rancho (2).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in New Mexico
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
BostonGene and Exigent Genomic INsight Study
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- BostonGene
- Recruiting in
- Albuquerque
- Registry record
- NCT06272864 · updated
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Observational
- Ages 40 to 75
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Recruiting in
- Albuquerque · Las Cruces · Rio Rancho
- Registry record
- NCT05334069 · updated
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Recruiting in
- Albuquerque · Las Cruces · Rio Rancho
- Registry record
- NCT06418204 · updated
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Observational
- All ages
- All sexes
- Sponsor
- Massive Bio, Inc.
- Recruiting in
- Albuquerque
- Registry record
- NCT03452774 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in New Mexico on ClinicalTrials.gov.
Lung cancer: recently updated in New Mexico
DESTINY-PANTUMOUR04
- Observational
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Farmington
- Registry record
- NCT07124000 · updated
Pan-tumor MRD Study
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Paradigm Health
- Recruiting in
- Farmington
- Registry record
- NCT06605404 · updated
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- N-Power Medicine
- Recruiting in
- Albuquerque
- Registry record
- NCT07028489 · updated
An External Control Arm Study in Non-Small Cell Lung Cancer
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- N-Power Medicine
- Recruiting in
- Albuquerque
- Registry record
- NCT07174388 · updated
Collection of Sputum and Labeling for Lung Cancer
- Observational
- Ages 21 and older
- All sexes
- Sponsor
- bioAffinity Technologies Inc.
- Recruiting in
- Albuquerque
- Registry record
- NCT03457415 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in New Mexico on ClinicalTrials.gov.
Melanoma: recently updated in New Mexico
Project: Every Child for Younger Patients With Cancer
- Observational
- Up to age 25
- All sexes
- Sponsor
- Children's Oncology Group
- Recruiting in
- Albuquerque
- Registry record
- NCT02402244 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in New Mexico on ClinicalTrials.gov.
Lymphoma: recently updated in New Mexico
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Observational
- All ages
- All sexes
- Sponsor
- Children's Oncology Group
- Recruiting in
- Albuquerque
- Registry record
- NCT01790152 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in New Mexico on ClinicalTrials.gov.
Pancreatic cancer: recently updated in New Mexico
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Observational
- Ages 50 to 75
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Albuquerque
- Registry record
- NCT04239573 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in New Mexico on ClinicalTrials.gov.
Ask about studies in New Mexico
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are observational, meaning researchers follow participants without assigning anything to test, as each study is coded in the registry.
Oncology Clinical Study does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections